Increase of nocturnal melatonin levels in hemodialyzed patients after parathyroidectomy -: A pilot study

被引:5
作者
Kancheva, R. [1 ]
Sulkova, S. [2 ]
Svara, F. [3 ]
Hill, M. [1 ]
Kanchev, L. [4 ]
Zofkova, I. [1 ]
机构
[1] Res Inst Endocrinol, Narodni Trida 8, CR-11694 Prague 1, Czech Republic
[2] Charles Univ Prague, Univ Hosp, Clin Gerontol & Metab, Div Nephrol, Hradec Kralove, Czech Republic
[3] Gen Univ Hosp, Dept Internal Med, Prague, Czech Republic
[4] New Bulgarian Univ, Sofia, Bulgaria
关键词
melatonin; hemodialyzed patients; hyperparathyroidism; parathyroidectomy;
D O I
10.33549/physiolres.931503
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In hemodialyzed patients hormonal disturbances are known to occur. However, melatonin levels have not been completely studied. The aim of the study was to find whether changes in calcaemia affect melatonin secretion. For this reason we followed the nocturnal serum concentrations of melatonin and parathyroid hormone (PTH) in 9 hemodialyzed patients (6 women and 3 men, aged 37-65 years) both before and 1-3 months after parathyroidectomy at 6 p.m., 9 p.m., 11 p.m., 2 a.m., 5 a.m. and 7 a.m. At 6 p.m. blood samples to evaluate the levels of calcium and phosphate were also collected. Parathyroidectomy resulted in an increase in nocturnal melatonin levels. As expected, the parathyroidectomy was followed by considerable PTH decrease. PTH showed no nocturnal variation before or after parathyroidectomy. Calcium levels significantly decreased after the operation while phosphate levels increased. In summary, in hemodialyzed patients with hyperparathyroidism, parathyroidectomy significantly increases the nocturnal secretion of melatonin. Relationships between the pineal gland and parathyroid glands have yet to be elucidated.
引用
收藏
页码:S181 / S185
页数:5
相关论文
共 14 条
[1]  
Abdel-Wanis M E, 2001, J Orthop Sci, V6, P193
[2]   Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism [J].
Chou, FF ;
Lee, CH ;
Chen, JB ;
Huang, SC ;
Lee, CT .
SURGERY, 2005, 137 (04) :426-430
[3]   MELATONIN AND IMMUNITY [J].
FRASCHINI, F ;
SCAGLIONE, F ;
FRANCO, P ;
DEMARTINI, G ;
LUCINI, V ;
STANKOV, B .
ACTA ONCOLOGICA, 1990, 29 (06) :775-776
[4]  
FRASER S, 1983, CLIN CHEM, V29, P396
[5]  
Illnerová H, 2000, PHYSIOL RES, V49, pS1
[6]  
Karasek M, 2005, NEUROENDOCRINOL LETT, V26, P653
[7]  
Karasek M, 2002, NEUROENDOCRINOL LETT, V23, P1
[8]   Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease [J].
Lüdemann, P ;
Zwernemann, S ;
Lerchl, A .
JOURNAL OF PINEAL RESEARCH, 2001, 31 (03) :222-227
[9]   Transformation in the PC-aided biochemical data analysis [J].
Meloun, M ;
Hill, M ;
Militky, J ;
Kupka, K .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (06) :553-559
[10]   Crucial problems in regression modelling and their solutions [J].
Meloun, M ;
Militky, J ;
Hill, M ;
Brereton, RG .
ANALYST, 2002, 127 (04) :433-450